CN Patent

CN101951917A — 用25-羟基维生素d3治疗高血压

Assigned to DSM IP Assets BV · Expires 2011-01-19 · 15y expired

What this patent protects

本发明公开了任选地与维生素D3(胆钙化固醇)组合的25-羟基维生素D3(麦角钙化固醇)用于治疗高血压的用途。本发明还公开了药物组合物的形式和剂量，以及用于制造药物的方法。

USPTO Abstract

本发明公开了任选地与维生素D3(胆钙化固醇)组合的25-羟基维生素D3(麦角钙化固醇)用于治疗高血压的用途。本发明还公开了药物组合物的形式和剂量，以及用于制造药物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101951917A
Jurisdiction
CN
Classification
—
Expires
2011-01-19
Drug substance claim
No
Drug product claim
No
Assignee
DSM IP Assets BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.